Ryo Akamatsu completed the master’s degree at the Graduate School of the Tokyo University of Science in 2002, and then joined Maruho Co., Ltd in Japan. From 2002 to 2014, he was primarily engaged in the formulation and process development of topical pharmaceuticals. Between 2014 and 2016, he served as the Manager of the Pharmaceutical Science Group and was leading the development of new formulations and novel technologies. In 2016, he was assigned to the subsidiary Cutanea Life Science in Pennsylvania, USA, where he held the position of Senior Manager in Product Development until 2019 and was involved in the formulation design and manufacturing of investigational medicinal products for both local and global projects. Upon returning to Japan in 2019, he assumed the role of Group Manager in the Pharmaceutical Science Group. Currently, he is leading the development of topical drug formulations and innovative technologies, including drug delivery system (DDS), while also contributing to the development of injectables and intranasal formulations. In recognition of his significant contributions to the field of pharmaceutical technology, he was awarded the title of The Master of Pharmaceutical Technology by the Academy of Pharmaceutical Science and Technology, Japan in 2021. His work exemplified a commitment to advancing pharmaceutical sciences through innovation, leadership, and a deep understanding of both traditional and cutting-edge pharmaceutical technologies.